Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway.

Acta pharmacologica Sinica - 1 Oct 2013

Apostolakis Stavros, Spandidos Demetrios

Abstract excerpt

Atherosclerosis is currently considered an inflammatory disease. Much attention has been focused on the potential role of inflammatory mediators as prognostic/diagnostic markers or therapeutic targets of atherosclerotic cardiovascular disease. CX3CL1 (or fractalkine) is a structurally and functionally unique chemokine with a well documented role in atherosclerosis. In its membrane bound form it promotes the firm...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Biomarkers
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Inflammation Mediators

Share to Molecular Epidemiology

Share to Prognosis

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 23974513
DOI: 10.1038/aps.2013.92
PMCID: PMC4002164

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway.PMID 23974513Read ↗

Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.Semantic proximity Read ↗

The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.Semantic proximity Read ↗

The role of chemokines in atherosclerosis: recent evidence from experimental models and population geneticsSemantic proximity Read ↗

Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debateSemantic proximity Read ↗

Fractalkine in Health and DiseaseSemantic proximity Read ↗

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.Semantic proximity Read ↗

CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survivalSemantic proximity Read ↗

Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.Semantic proximity Read ↗

Chemokines and atherosclerosisSemantic proximity Read ↗

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.Semantic proximity Read ↗

Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.Semantic proximity Read ↗

Atherosclerosis: A Comprehensive Review of Molecular Factors and MechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.